The skin is involved in over 90% of cases of systemic mastocytosis (Demis 1963) . We describe a patient in whom cutaneous disease first appeared fifteen years after the onset of symptoms. The symptoms were back pain due to osteoporosis and subjective sensations, presumably resulting from the release of pharmacological mediators.
Case report
A 3 1-year-old accountant had developed backache in adolescence. After exercise or a fall the pain was disproportionately severe. Trauma also precipitated attacks lasting a few minutes which the patient described 'as though somebody had pressed a panic button': increased awareness, racing and forceful heartbeats were typical. There was a call to stool, but no diarrhoea. In his late teens X-ray revealed osteoporosis and within a few years there was collapse of four vertebral bodies in the thoraco-lumbar region (Figure 1 ). He had received injections of testosterone esters (Sustanon) since 1982, when his testosterone level was found to be low.
At the age of 30 (1983), shortly after starting his testosterone injections, typical lesions of urticaria pigmentosa appeared on his chest. Skin biopsy confirmed the excess of mast cells in the lesions. A transiliac biopsy also showed increased numbers of mast cells, many close to the bone surface ( Figure 2 ). Gallium scanning suggested a generalized increase in mast cells in all bones and localized increases in the spleen and right clavicle.
Other normal results included haemoglobin, full blood count, ESR, urea and electrolytes, liver function and clotting studies; no circulating heparin was detected.
Discussion
Systemic mastocytosis is a rare disease and there is remarkably little information available regarding the frequency of particular organ involvement (Demis 1963) or the prognosis. The patient reported has a considerable handicap already. He walks slowly with a stick and is stooped. The recent 'panic' attacks are annoying but not lifethreatening. Skeletal abnormalities have been described in nearly 10% of patients with systemic mastocytosis. Osteosclerosis is more common than osteoporosis. The mechanism by which osteoporosis is produced is not clear, although chronic heparin release has been postulated. In this case it may be partly due to his hypogonadism.
Release of pharmacologically active mediators by the mast cells can lead to different symptoms.
These may range from mild flushing attacks to profound hypotension, dyspnoea and shock (Roberts et al. 1982 ). Histamine may be involved but prostaglandin D2 now seems the likely cause of severe symptoms (Kootte et al. 1983 ). Assays are available in a few centres for blood and urinary histamines and a urinary metabolite of prostaglandin D2
The control of symptoms has been attempted using H1 and H2 receptor antagonists, high-dose acetylsalicylic acid and disodium cromoglycate (Lindskov et al. 1984) . None is consistently effective. There are no reports on the prognostic value of radiotherapy or chemotherapy. It is therefore difficult to know how aggressive therapy should be, and whether this could possibly avert the fulminating disease which develops in some cases. It has been suggested that gallium scanning may be useful to evaluate the extent of the disease (Ensslen et al. 1983) . A further scan in a few years time may give information about progression of the mast cell load and its distribution.
Awareness of its many manifestations is essential for early diagnosis of systemic mastocytosis. This case illustrates two important points. First, the early symptoms may be vague and it may be hard to substantiate mastocytosis. Second, the onset of skin lesionsthough very helpful clinicallymay be delayed for many years and, indeed, may never appear. The definition of retroperitoneal structures by abdominal computed tomography (CT) depends on the presence of contrasting low-density fat (Isherwood & Forbes 1980) . This limits the usefulness of the technique in the wasted patient. We describe such a case, in whom the result was misleading.
Case report A 32-year-old white male textile dyer was referred in July 1984 because of 8-10 weeks myalgia, approximately 17 kg weight loss and intermittent central abdominal pain, vomiting and diarrhoea. He volunteered that he had used intravenous amphetamines regularly for 5 years but denied abuse of other drugs; questioning revealed that he had also engaged in homosexual practices during this time. He was wasted and anaemic; there was no fever, rash or lymphadenopathy. Blood pressure was 110/70mmHg, pulse 100/min and regular. There was no cardiac murmur. He had 8 cm smooth, slightly tender hepatomegaly but no splenomegaly. There was gross muscle wasting but no undue muscle tenderness; limb reflexes were preserved.
Investigations on admission revealed a normochromic normocytic anaemia (9.9 g/dl) and neutrophil leukocytosis (18 x 109/l). There was no eosinophilia. Serum urea was 15.3 mmol/l, creatinine 153 jimol/l, albumin 26 g/l and globulins 39 g/l. Serum alkaline phosphatase, aspartate transaminase and gamma-glutamyl transpeptidase concentrations were minimally raised but bilirubin normal. Chest X-ray, ECG and thyroid function were normal. Hepatitis B surface antigen (HBsAg), HBeAg and antibodies to hepatitis B core antigen were present in serum. Urine, sputum and blood cultures were sterile. Serum C3 and C4 concentrations were normal. Smooth muscle antibodies were present at a titre of 1:256; mitochondrial and antinuclear antibodies were absent.
During the subsequent week he developed progressive renal failure and had several episodes of pulmonary oedema responsive to diuretics. Echocardiography showed poor left ventricular function with ejection fraction 21%. Abdominal ultrasound scan showed normal liver density and 'Accepted 15 April 1985 0141-0768/85/100867-03/$02.00/0 i 1985 The Royal Society of Medicine
